USANA Health Sciences ups revenues 22% in Q4

• USANA Health Sciences (NYSE:USNA) Q4 results: Revenues: $227.9M (+22.3%); COGS: $37.5M (+10.9%); SG&A: $51.2M (+29.0%); Operating Income: $32.6M (+12.4%); Net Income: $21.3M (+4.9%); EPS: $1.65 (+17.0%).
• FY2014 results: Revenues: $790.5M (+10.1%); COGS: $140.8M (+10.5%); SG&A: $184.5M (+11.0%); Operating Income: $116.1M (-0.5%); Net Income: $76.6M (-3.0%); EPS: $5.6 (+0.7%); Quick Assets: $111.1M (-23.9%).
• 2015 Guidance: Net Sales: $850M - 870M; EPS: $6.40 - 6.70.